Capitol Health Limited
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CAJ.AX research report →
Price Chart
About the company
Capitol Health Limited is an Australian company specializing in delivering various medical imaging techniques and associated support services to the nation's healthcare sector. Its extensive range of diagnostic offerings includes general radiography, magnetic resonance imaging (MRI), ultrasound, mammography, Doppler scans, orthopantomograms (OPGs), echocardiograms, computed tomography (CT) scans (encompassing CT angiography and cone beam CT), nuclear medicine, bone density assessments, and fluoroscopy. As of June 30, 2022, the company managed a network of 63 clinics located across Victoria, Tasmania, Western Australia, and South Australia.
- CEO
- Justin Samuel Walter MPH (JCU)
- IPO
- 2006
- Employees
- 1,000
- HQ
- East Melbourne, VIC, AU
Get TickerSpark's AI analysis on CAJ.AX
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $413.13M
- P/E
- -27.50
- Fwd P/E
- 19.35
- PEG
- -0.28
- P/S
- 1.76
- P/B
- 3.69
- EV/EBITDA
- 22.77
- Div Yield
- 2.33%
- Gross Margin
- 19.05%
- Op Margin
- 9.46%
- Net Margin
- -6.33%
- ROE
- -11.98%
- ROIC
- 8.55%
Latest fiscal year · YoY change
- Revenue
- $234.82M+12.0%
- Gross Profit
- $44.74M+20.2%
- Op Income
- $22.22M
- Net Income
- $-14,853,000-30.4%
- EPS
- $-0.01-29.6%
- OCF Growth
- -3.5%
- FCF Growth
- -10.7%
- 52W High
- $0.40
- 52W Low
- $0.22
- 50D MA
- $0.38
- 200D MA
- $0.31
- Beta
- 0.63
- RSI (14)
- 56
- Avg Volume
- 2.36M
No earnings-call transcripts are available for CAJ.AX yet.
- Free Float
- 87.0%
- Shares Outstanding
- 1.07B
- Float Shares
- 934.04M
Our CAJ.AX coverage
Recent articles, reports, and earnings notes.
No research on CAJ.AX yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate CAJ.AX report →